The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $6,097,304 were sold by Sabag Mark on May 08 ’25. At $18.04 per share, Sabag Mark sold 337,915 shares. The insider’s holdings dropped to 150,996 shares worth approximately $2.5 million following the completion of this transaction.
Also, Sabag Mark purchased 337,915 shares, netting a total of over 6,097,324 in proceeds.
Before that, Daniell Richard had sold 70,961 shares from its account. In a trade valued at $1,128,642, the Exec. VP, European Commercial traded Teva- Pharmaceutical Industries Ltd. ADR shares for $15.91 each. Upon closing the transaction, the insider’s holdings decreased to 70,961 shares, worth approximately $0.8 million.
As published in a research note from JP Morgan on May 12, 2025, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from a Neutral to an Overweight and the price target has been revised to $23. Analysts at Argus upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early July. As of March 08, 2024, JP Morgan has increased its “an Underweight” rating to a “Neutral” for TEVA. Earlier on February 12, 2024, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for TEVA stock which previously was a “a Neutral”.
Analyzing TEVA Stock Performance
During the last five days, there has been a drop of approximately -2.01%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have dropped approximately -24.91%. Shares of the company reached a 52-week high of $22.40 on 01/28/25 and a 52-week low of $12.47 on 04/10/25. A 50-day SMA is recorded $15.54, while a 200-day SMA reached $17.53.
Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
According to the 24-hour chart, there is a support level at 16.33, which, if violated, would cause prices to drop to 16.12. In the upper region, resistance lies at 16.82. The next price resistance is at 17.10. RSI (Relative Strength Index) is 53.25 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.20, which suggests the price will decrease in the coming days. Percent R is at 68.36%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
